ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 67 filers reported holding ASTRIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $208,250 | -37.4% | 25,000 | 0.0% | 0.04% | -46.4% |
| Q1 2023 | $332,500 | -10.7% | 25,000 | 0.0% | 0.07% | -13.8% |
| Q4 2022 | $372,250 | +64.7% | 25,000 | 0.0% | 0.08% | +50.9% |
| Q3 2022 | $226,000 | +201.3% | 25,000 | 0.0% | 0.05% | +165.0% |
| Q2 2022 | $75,000 | -55.4% | 25,000 | 0.0% | 0.02% | -52.4% |
| Q1 2022 | $168,000 | +24.4% | 25,000 | 0.0% | 0.04% | +61.5% |
| Q4 2021 | $135,000 | -38.9% | 25,000 | 0.0% | 0.03% | -25.7% |
| Q3 2021 | $221,000 | – | 25,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 911,736 | $8,060,000 | 2.93% |
| VR Adviser, LLC | 538,999 | $4,765,000 | 0.61% |
| COMMODORE CAPITAL LP | 239,270 | $2,115,000 | 0.56% |
| Perceptive Advisors | 1,959,652 | $17,323,000 | 0.25% |
| Cormorant Asset Management, LP | 552,903 | $4,888,000 | 0.20% |
| RA Capital Management | 1,262,193 | $11,158,000 | 0.16% |
| Soleus Capital Management, L.P. | 112,499 | $994,000 | 0.16% |
| ArchPoint Investors | 28,247 | $250,000 | 0.08% |
| Ikarian Capital, LLC | 87,580 | $775,000 | 0.06% |
| Old Well Partners, LLC | 12,116 | $107,000 | 0.06% |